#1 Clinical Trials Search in Europe

Nortriptyline Hydrochloride

Nortriptyline Hydrochloride, a tricyclic antidepressant, is being studied in various clinical trials to explore its potential in treating different medical conditions. These trials aim to evaluate the drug’s effectiveness, safety, and optimal dosing for conditions ranging from gastrointestinal disorders to skin conditions and cancer treatments. The research involves both oral and topical applications of Nortriptyline Hydrochloride, often in combination with other medications.

Table of Contents

What is Nortriptyline Hydrochloride?

Nortriptyline Hydrochloride, also known by brand names such as Pamelor, Allegron, and Norpress, is a medication that belongs to a class of drugs called tricyclic antidepressants (TCAs)[1]. It works by affecting the balance of certain chemicals in the brain, particularly neurotransmitters that are involved in mood regulation and pain perception[2].

Medical Uses of Nortriptyline

Nortriptyline is used to treat various conditions, including:

  • Depression: It is primarily used as an antidepressant, especially in elderly patients (60-80 years old)[3].
  • Idiopathic Gastroparesis: This is a condition where the stomach takes too long to empty its contents. Nortriptyline is being studied for its potential to improve symptoms of this disorder[4].
  • Functional Dyspepsia: Also known as non-ulcer dyspepsia, this condition causes pain or discomfort in the upper abdomen. Nortriptyline is being investigated for its ability to alleviate these symptoms[5].
  • Small Cell Carcinoma: In combination with other drugs, nortriptyline is being studied for its potential in treating this type of cancer[1].
  • Skin Conditions: Some studies are exploring the use of nortriptyline in topical formulations for conditions like psoriasis and atopic dermatitis[6].

How Nortriptyline is Administered

Nortriptyline can be administered in various ways, depending on the condition being treated:

  • Oral tablets or capsules: This is the most common form for treating depression and other systemic conditions. The dosage may start low and gradually increase over time[4].
  • Topical formulations: For skin conditions, nortriptyline may be applied directly to the skin in cream or ointment form, often in combination with other medications[6].

It’s important to note that the dosage and administration method should always be determined by a healthcare professional based on the individual patient’s condition and needs.

Current Research and Clinical Trials

Nortriptyline is currently being studied in several clinical trials for various conditions:

  • Gastroparesis: A study is comparing nortriptyline to placebo for improving symptoms of idiopathic gastroparesis[4].
  • Cancer Treatment: Researchers are investigating the combination of nortriptyline with paclitaxel for treating relapsed small cell carcinoma[1].
  • Skin Conditions: Several studies are exploring topical formulations of nortriptyline, often in combination with other drugs, for treating psoriasis and atopic dermatitis[7].
  • Functional Dyspepsia: A trial is assessing whether nortriptyline can improve symptoms and quality of life in patients with this condition[2].

Potential Side Effects and Safety Considerations

Like all medications, nortriptyline can cause side effects. Some potential side effects include:

  • Dry mouth
  • Constipation
  • Blurred vision
  • Drowsiness
  • Dizziness
  • Weight gain

It’s important to note that side effects can vary depending on the dosage and the individual. Some studies are specifically looking at ways to minimize side effects, such as by adjusting the dosage or by using genetic testing to predict how a patient might metabolize the drug[2].

Patients should always discuss potential risks and benefits with their healthcare provider before starting nortriptyline or any new medication. It’s also crucial to inform your doctor about all other medications you’re taking, as nortriptyline can interact with various drugs.

Aspect Details
Conditions Studied Idiopathic gastroparesis, small cell carcinoma, atopic dermatitis, plaque psoriasis, functional dyspepsia, non-ulcer dyspepsia
Administration Methods Oral (capsules, tablets), Topical (creams, ointments)
Dosage Ranges Varies by trial: 10mg to 75mg for oral, 0.05% to 0.1% for topical
Trial Durations 3 weeks to 6 months, with some including follow-up periods
Combination Therapies With paclitaxel (for cancer), with loratadine (for skin conditions), with mometasone furoate (for psoriasis)
Primary Outcomes Measured Symptom improvement, reduction in disease markers, safety and tolerability, quality of life changes
Safety Monitoring Adverse events, physical exams, vital signs, concomitant medications, specific condition-related side effects

FAQ

  • What conditions are being studied with Nortriptyline Hydrochloride in clinical trials? Clinical trials are exploring the use of Nortriptyline Hydrochloride for various conditions including idiopathic gastroparesis, small cell carcinoma, atopic dermatitis, plaque psoriasis, functional dyspepsia, and non-ulcer dyspepsia.
  • How is Nortriptyline Hydrochloride administered in these trials? Depending on the trial and condition being studied, Nortriptyline Hydrochloride is administered either orally (as capsules or tablets) or topically (as creams or ointments). Some trials use it alone, while others combine it with other medications.
  • What are the potential benefits of using Nortriptyline Hydrochloride in these trials? Potential benefits being investigated include improvement in gastroparesis symptoms, reduction of psoriatic infiltrate in skin conditions, enhanced effectiveness in cancer treatment when combined with chemotherapy, and relief of abdominal pain or discomfort in dyspepsia.
  • Are there any side effects being monitored in these trials? Yes, the trials are closely monitoring for side effects. Common areas of focus include treatment-emergent adverse events, changes in vital signs, and specific side effects related to each condition being studied. The goal is to establish the safety profile of Nortriptyline Hydrochloride for these new applications.
  • How long do these clinical trials typically last? The duration of the trials varies depending on the condition and study design. Some trials last for a few weeks, while others extend up to several months. For example, the gastroparesis trial lasted 15 weeks, while the functional dyspepsia trial had a 12-week treatment period with follow-ups at 3 and 6 months.

Ongoing Clinical Trials on Nortriptyline Hydrochloride

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Germany Greece Italy Spain

  • Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Idiopathic Gastroparesis: A digestive disorder where the stomach takes too long to empty its contents, without a known cause. Symptoms may include nausea, vomiting, and feeling full quickly when eating.
  • Small Cell Carcinoma: A type of fast-growing cancer that most commonly begins in the lungs, but can affect other parts of the body. It's named for the size of the cancer cells when viewed under a microscope.
  • Atopic Dermatitis: A chronic skin condition characterized by itchy, inflamed skin. It's a type of eczema that commonly begins in childhood.
  • Plaque Psoriasis: A skin condition that causes dry, raised, and red skin lesions (plaques) covered with silvery scales. It's the most common type of psoriasis.
  • Functional Dyspepsia: A chronic disorder of the upper digestive tract, causing pain or discomfort in the upper abdomen without an identifiable cause.
  • Non-Ulcer Dyspepsia: A type of indigestion without evidence of an ulcer or other specific disease. Symptoms may include upper abdominal pain, nausea, and bloating.
  • Tricyclic Antidepressant: A class of medications primarily used to treat depression, but also used for other conditions such as chronic pain and sleep disorders.
  • Placebo: A substance with no active therapeutic effect, used as a control in testing new drugs to evaluate the effectiveness of a treatment.
  • Dose Escalation: A method of administering a drug where the dose is gradually increased over time to find the most effective dose with tolerable side effects.
  • Topical Application: Administration of a medication directly to the skin or mucous membranes, often in the form of creams, ointments, or gels.

References

  1. https://clinicaltrials.gov/study/NCT02881125
  2. https://clinicaltrials.gov/study/NCT03652571
  3. https://clinicaltrials.gov/study/NCT00000377
  4. https://clinicaltrials.gov/study/NCT00765895
  5. https://clinicaltrials.gov/study/NCT00547703
  6. https://clinicaltrials.gov/study/NCT00544687
  7. https://clinicaltrials.gov/study/NCT00721331